New research indicates that adults living with both epilepsy and hearing loss may significantly reduce their risk of developing dementia by using hearing aids. A study published in JAMA Neurology …
Type 2 Diabetes
-
-
Combining Strength Training and Cardio Reduces Type 2 Diabetes Risk, Study Shows A study published in the Journal of the American Medical Association (JAMA) found that adults who engaged in …
-
Researchers at the Massachusetts Institute of Technology (MIT) have developed a fluorescent nanosensor capable of detecting hydrogen sulfide in the gut, a critical biomarker for inflammatory bowel disease (IBD). Published …
-
Recent research indicates that both low and high blood pressure levels are independently associated with an increased risk of developing Alzheimer’s disease and dementia-related mortality. While traditional clinical focus has …
-
Type 2 Diabetes and Periodontitis: Why Glycemic Control Isn’t the Only Factor Recent research indicates that individuals with type 2 diabetes face a significantly higher risk of developing periodontitis, regardless …
-
Long-term treatment of high blood pressure using renin–angiotensin system (RAS) inhibitors may lead to kidney damage in some patients, according to a discovery by University of Virginia (UVA) School of …
-
Common Hypertension Drugs and Kidney Outcomes in Type 2 Diabetes Patients: What the Latest Research Shows Recent studies have raised concerns about the long-term effects of certain hypertension medications on …
-
The Power of Language: How Medical Naming Impacts Patient Care In medicine, names are far more than simple labels. They serve as the foundation for how we diagnose, research, and …
-
Understanding the Link Between Gestational Diabetes and Long-Term Metabolic Health For many expectant parents, a diagnosis of gestational diabetes (GDM) can feel like a temporary hurdle to be managed until …
-
GLP-1 Receptor Agonists: A New Frontier in Addiction Treatment? The landscape of addiction medicine is evolving rapidly. As a physician, I have closely followed the clinical impact of GLP-1 receptor …